Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriKe: Ketorolac vs Cortisone vs Combination for Knee Osteoarthritis
NCT05336968Phase 4Recruiting
- Start
- Sep 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac in osteoarthritis (OA) (3 arms). Primary endpoint: Modified Knee Injury and Osteoarthritis Outcome Score at 24 weeks. Started Sep 2022; status: recruiting.
02
Drugs
ketorolac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05336968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05336968.